Posted inClinical Updates news
Cost-Effectiveness Analysis of Menopausal Hormone Therapy: Integrating Risk-Benefit Profiles and Economic Models
This review synthesizes current evidence on menopausal hormone therapy's cost-effectiveness, highlighting findings from a 2026 Markov model analysis and contextualizing with pivotal studies on health outcomes and economic implications of MHT.